India, Oct. 12 -- Days after banning the use of Coldrif cough syrup across Punjab, the Directorate of Health and Family Welfare has now issued an urgent directive discontinuing the use of eight specific intravenous (IV) fluids and injectable drugs manufactured by three pharmaceutical companies, after suspected cases of adverse drug reactions (ADRs) were reported from multiple health facilities in the state.

The directive, issued under Memo No. Pb/2025/3896-3104 from the Directorate's Chandigarh office, is addressed to all civil surgeons, medical superintendents, and senior officials of government hospitals, including Mata Kaushalya Hospital Patiala and District Hospital Jalandhar. It mandates the immediate stoppage of use, issue, and pro...